These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3814175)

  • 21. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
    Roy D; Snodgrass WR
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic activation of 2-methylfuran by rat microsomal systems.
    Ravindranath V; Boyd MR
    Toxicol Appl Pharmacol; 1985 May; 78(3):370-6. PubMed ID: 4049387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo.
    Miller MG; Jollow DJ
    Drug Metab Dispos; 1984; 12(3):271-9. PubMed ID: 6145552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
    Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
    Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of ortho-bromophenol in the nephrotoxicity of bromobenzene in rats.
    Lau SS; Monks TJ; Greene KE; Gillette JR
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):539-49. PubMed ID: 6710503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic activation of 1,1-dichloroethylene by mouse lung and liver microsomes.
    Forkert PG; Hofley M; Racz WJ
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1496-9. PubMed ID: 3664363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model for fatal halothane hepatitis in the guinea pig.
    Lind RC; Gandolfi AJ; Hall PM
    Anesthesiology; 1994 Aug; 81(2):478-87. PubMed ID: 8053598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro.
    Madyastha KM; Moorthy B
    Chem Biol Interact; 1989; 72(3):325-33. PubMed ID: 2691105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
    Masubuchi Y; Araki J; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations.
    Miller KJ; Anderholm DC; Ames MM
    Biochem Pharmacol; 1986 May; 35(10):1737-42. PubMed ID: 3707603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide.
    Roberts SA; Price VF; Jollow DJ
    Toxicol Appl Pharmacol; 1990 Sep; 105(2):195-208. PubMed ID: 2219115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of the behavioural effects of amineptine after acute, subacute and chronic administration of phenobarbital in mice.
    De Angelis L
    In Vivo; 1989; 3(5):331-4. PubMed ID: 2519874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
    Madan A; Parkinson A
    Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
    Gemma S; Sbraccia M; Testai E; Vittozzi L
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):45-7. PubMed ID: 7698083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro covalent binding of cismethrin, bioresmethrin, and their common alcohol to hepatic proteins.
    Hoellinger H; Sonnier M; Gray AJ; Connors TA; Pichon J; Nguyen HN
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):11-8. PubMed ID: 3966234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covalent binding of diethylstilbestrol to microsomal protein in vitro correlates with the organotropism of its carcinogenicity.
    Haaf H; Metzler M
    Carcinogenesis; 1985 Apr; 6(4):659-60. PubMed ID: 4039228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes.
    Decker CJ; Doerge DR
    Biochem Pharmacol; 1992 Feb; 43(4):881-8. PubMed ID: 1371686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
    Le CT; Hollaar L; van der Valk EJ; van der Laarse A
    J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.